Brief: Ligand Pharmaceuticals Q1 EPS $2.33
04/05/2023 23:04
May 4 (Reuters) - Ligand Pharmaceuticals Q1 EPS USD 2.33 * Q1 revenue USD 43.979 million * Q1 net income USD 41.949 million * Q1 pretax profit USD 55.536 million * Outlook FY revenue USD 124-128 million
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan